Rilmenidine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rilmenidine" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

11^th place

8^th place

5,043^rd place

3,807^th place

doi.org

Remková A, Kratochvíl'ová H (August 2002). "Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension". Journal of Human Hypertension. 16 (8): 549–55. doi:10.1038/sj.jhh.1001427. PMID 12149660.
Cobos-Puc L, Aguayo-Morales H (2019). "Cardiovascular Effects Mediated by Imidazoline Drugs: An Update". Cardiovascular & Hematological Disorders Drug Targets. 19 (2): 95–108. doi:10.2174/1871529X18666180629170336. PMID 29962350. S2CID 49644599.
Bousquet P, Hudson A, García-Sevilla JA, Li JX (January 2020). "Imidazoline Receptor System: The Past, the Present, and the Future". Pharmacological Reviews. 72 (1): 50–79. doi:10.1124/pr.118.016311. PMID 31819014.
Bennett DF, Goyala A, Statzer C, Beckett CW, Tyshkovskiy A, Gladyshev VN, et al. (February 2023). "Rilmenidine extends lifespan and healthspan in Caenorhabditis elegans via a nischarin I1-imidazoline receptor". Aging Cell. 22 (2): e13774. doi:10.1111/acel.13774. PMC 9924948. PMID 36670049.
Yalçın MB, Bora ES, Çakır A, Akbulut S, Erbaş O (2023). "Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine". Acta Cirurgica Brasileira. 38: e387823. doi:10.1590/acb387823. PMC 10691181. PMID 38055406.

Remková A, Kratochvíl'ová H (August 2002). "Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension". Journal of Human Hypertension. 16 (8): 549–55. doi:10.1038/sj.jhh.1001427. PMID 12149660.
Cobos-Puc L, Aguayo-Morales H (2019). "Cardiovascular Effects Mediated by Imidazoline Drugs: An Update". Cardiovascular & Hematological Disorders Drug Targets. 19 (2): 95–108. doi:10.2174/1871529X18666180629170336. PMID 29962350. S2CID 49644599.
Bousquet P, Hudson A, García-Sevilla JA, Li JX (January 2020). "Imidazoline Receptor System: The Past, the Present, and the Future". Pharmacological Reviews. 72 (1): 50–79. doi:10.1124/pr.118.016311. PMID 31819014.
Bennett DF, Goyala A, Statzer C, Beckett CW, Tyshkovskiy A, Gladyshev VN, et al. (February 2023). "Rilmenidine extends lifespan and healthspan in Caenorhabditis elegans via a nischarin I1-imidazoline receptor". Aging Cell. 22 (2): e13774. doi:10.1111/acel.13774. PMC 9924948. PMID 36670049.
Yalçın MB, Bora ES, Çakır A, Akbulut S, Erbaş O (2023). "Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine". Acta Cirurgica Brasileira. 38: e387823. doi:10.1590/acb387823. PMC 10691181. PMID 38055406.

Cobos-Puc L, Aguayo-Morales H (2019). "Cardiovascular Effects Mediated by Imidazoline Drugs: An Update". Cardiovascular & Hematological Disorders Drug Targets. 19 (2): 95–108. doi:10.2174/1871529X18666180629170336. PMID 29962350. S2CID 49644599.